دوره 15، شماره 12 - ( 9-1396 )                   جلد 15 شماره 12 صفحات 806-803 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farimani M, Poorolajal J, Rabiee S, Bahmanzadeh M. Successful pregnancy and live birth after intrauterine administration of autologous platelet-rich plasma in a woman with recurrent implantation failure: A case report. IJRM 2017; 15 (12) :803-806
URL: http://ijrm.ir/article-1-931-fa.html
Successful pregnancy and live birth after intrauterine administration of autologous platelet-rich plasma in a woman with recurrent implantation failure: A case report. International Journal of Reproductive BioMedicine. 1396; 15 (12) :803-806

URL: http://ijrm.ir/article-1-931-fa.html


چکیده:   (3167 مشاهده)
Background: Platelets contain a significant amount of growth factors that have positive effects on local tissue repair and endometrial receptivity.
Case: Here we present a 45-yr-old woman with primary infertility and two failed in vitro fertilization (IVF) cycles who was candidate to receive donor eggs. Five consecutive frozen-thawed embryo transfer cycles with good quality embryos were performed within 2 yr. With the diagnosis of recurrent implantation failure (RIF), the patient was treated for improving endometrial receptivity with intrauterine administration of autologous platelet-rich plasma (PRP), 24 hr before embryo transfer. The patient gave birth to a healthy baby boy weighing 2350 gr in the cesarean section.
Conclusion: Extensive literature search suggests that this is the first successful pregnancy after administration of PRP in a woman with RIF. Local administration of PRP before embryo transfer may play a vital role in successful implantation
نوع مطالعه: Original Article |

فهرست منابع
1. Zeyneloglu HB, Onalan G. Remedies for recurrent implantation failure. Semin Reprod Med 2014; 32: 297-305. [DOI:10.1055/s-0034-1375182]
2. Magdi Y, El-Damen A, Fathi AM, Abdelaziz AM, Abd-Elfatah Youssef M, Abd-Allah AA, et al. Revisiting the management of recurrent implantation failure through freeze-all policy. Fertil Steril 2017; 108: 72-77. [DOI:10.1016/j.fertnstert.2017.04.020]
3. Toth B, Würfel W, Germeyer A, Hirv K, Makrigiannakis A, Strowitzki T. Disorders of implantation–are there diagnostic and therapeutic options? J Reprod Immunol 2011; 90: 117-123. [DOI:10.1016/j.jri.2011.05.002]
4. Ideta A, Sakai S, Nakamura Y, Urakawa M, Hayama K, Tsuchiya K, et al. Administration of peripheral blood mononuclear cells into the uterine horn to improve pregnancy rate following bovine embryo transfer. Anim Reprod Sci 2010; 117: 18-23. [DOI:10.1016/j.anireprosci.2009.04.004]
5. Zwiep T, Humphrey R, Fortin D, Inculet RI, Malthaner RA. Autologous platelet rich plasma and concentrated platelet poor plasma are safe in patients requiring lobectomies but do not reduce the duration of air leak: a randomized controlled trial. Ann Surg Int 2016; 2: ASI-2-011.
6. Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med 2015; 8: 1286-1290.
7. Farimani M, Bahmanzadeh M, Poorolajal J. A New Approach Using Autologous Platelet-Rich Plasma (PRP) to Treat Infertility and To Improve Population Replacement Rate. J Res Health Sci 2016; 16: 172-173.
8. Farimani M, Bahmanzadeh M, Azami N, Mohammadpoor N. High pregnancy rates with administration of autologous platelet-rich plasma in ART patients with recurrent implantation failure. Proceedings of 15th intrnational congress of obstetric and Gynecology; 4-7 October; Tehran; 2016: 68.
9. Fung M, Grossman B, Hillyer C, Westhoff C. American Assocation of Blood Banks. 18th Ed. Bethesda, Md: American Association of Blood Banks; 2014: 645-661.
10. Das M, Holzer HE. Recurrent implantation failure: gamete and embryo factors. Fertil Steril 2012; 97: 1021-1027. [DOI:10.1016/j.fertnstert.2012.02.029]
11. D Ly K, Aziz N, Safi J, Agarwal A. Evidence-based management of infertile couples with repeated implantation failure following IVF. Curr Women's Health Rev 2010; 6: 200-218. [DOI:10.2174/157340410792007073]
12. Dimauro I, Grasso L, Fittipaldi S, Fantini C, Mercatelli N, Racca S, et al. Platelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model. PLOS One 2014; 9: e102993. [DOI:10.1371/journal.pone.0102993]
13. Sampson S, Aufiero D, Meng M, Bledin A, Gillette T, Zall M. Platelet-rich plasma therapy as a first-line treatment for severe achilles tendon tear: a case report. Int J Ther Rehabil 2011; 18: 101-106. [DOI:10.12968/ijtr.2011.18.2.101]
14. Wasterlain AS, Braun HJ, Dragoo JL. Contents and Formulations of Platelet Rich Plasma. In: Maffulli N (eds). Platelet Rich Plasma in Musculoskeletal Practice. Springer, London; 2016: 1-29. [DOI:10.1007/978-1-4471-7271-0_1]
15. Srivastava A, Sengupta J, Kriplani A, Roy KK, Ghosh D. Profiles of cytokines secreted by isolated human endometrial cells under the influence of chorionic gonadotropin during the window of embryo implantation. Reprod Biol Endocrinol 2013; 11: 116. [DOI:10.1186/1477-7827-11-116]
16. Anitua E, de la Fuente M, Ferrando M, Quintana F, Larreategui Z, Matorras R, et al. Biological effects of plasma rich in growth factors (PRGF) on human endometrial fibroblasts. Eur J Obstet Gynecol Reprod Biol 2016; 206: 125-130 [DOI:10.1016/j.ejogrb.2016.09.024]
17. Yu H, Gao SH, Tang H, Chen H, Deng ZH, Yang L, et al. Growth hormone intrauterine perfusion combined with replacement cycle in the treatment of non-response thin endometrium: report of 5 cases. Int J Clin Exp Med 2016; 9: 11982-11989.
18. Furukawa Y, Kawano Y, Fukuda J, Matsumoto H, Narahara H. The production of vascular endothelial growth factor and metalloproteinase via protease-activated receptor in human endometrial stromal cells. Fertil Steril 2009; 91: 535-541. [DOI:10.1016/j.fertnstert.2007.11.080]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به International Journal of Reproductive BioMedicine می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb